Court rules for Pfizer in Lipitor patent case (Reuters)

RSS News User · 17th December 2005, 09:45 AM

<p><a href="http://us.rd.yahoo.com/dailynews/rss/business/*http://news.yahoo.com/s/nm/20051216/bs_nm/pfizer_dc"><img src="http://us.news3.yimg.com/us.i2.yimg.com/p/nm/20051217/2005_12_16t170830_450x301_us_pfizer.jpg?x=130& y=86&sig=gnl5HxKGyQMPUhIsQ5IIoQ--" align="left" height="86" width="130" alt="The entrance of Pfizer World headquaters in New York City, August 31, 2003. A federal judge on Friday upheld the validity of two key U.S. patents on Pfizer Inc.'s Lipitor cholesterol drug, lending a setback to Indian drugmaker Ranbaxy Laboratories Ltd which had hoped to introduce a generic version of the medicine. (Jeff Christensen/Reuters)" border="0" /></a>Reuters - A federal judge on Friday upheld the
validity of two key U.S. patents on Pfizer Inc.'s
Lipitor cholesterol drug, blocking a generic version of the
drug that threatened Pfizer's largest source of revenue.</p><br clear=all>

View the entire article: Court rules for Pfizer in Lipitor patent case (Reuters)